A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease Psychosis

J Clin Psychopharmacol. 2023 Sep-Oct;43(5):481-482. doi: 10.1097/JCP.0000000000001743. Epub 2023 Aug 4.

Authors

Nicholas Tkach, Douglas J Opler

PMID: 37683250
DOI: 10.1097/JCP.0000000000001743

No abstract available

Publication types

Letter

MeSH terms

Cyproheptadine / therapeutic use
Humans
Parkinson Disease* / complications
Parkinson Disease* / drug therapy
Psychotic Disorders* / drug therapy
Psychotic Disorders* / etiology

Substances

Cyproheptadine